$MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
$11.41
▲+0.26%+$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMoonLake Immunotherapeutics Class A Ordinary Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is MLTX up today? It is at $11.41 (+0.26%), and our scanner flagged it 89 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MLTX spikes, and full due diligence on MLTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MLTX 89 times in the last 30 days. Create a free account to track $MLTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MLTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MLTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing8-KOther Material EventSep 30, 2026 · 5 days agoAcross every filing on file, supply equal to 131.6% of the tradeable float is in play - 131.6% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
9,000,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $20/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Reich Kristian Officer | Sold (automatic/other) | -1K | sold <0.1% | 2.71M | $22K at $20.00 | Jul 27, 26 |
Reich Kristian Officer | Sold (automatic/other) | -2K | sold <0.1% | 2.71M | $49K at $20.00 | Jul 22, 26 |
Reich Kristian Officer | Sold (automatic/other) | -50K 0.06% of company | sold 1.8% | 2.71M | $1.0M at $20.02 | Jul 21, 26 |
Reich Kristian Officer | Sold (automatic/other) | -44K 0.05% of company | sold 1.6% | 2.76M | $878K at $20.09 | Jul 20, 26 |
Reich Kristian Officer | Sold (automatic/other) | -16K 0.02% of company | sold 0.6% | 2.81M | $322K at $20.01 | Jul 15, 26 |
Santos Da Silva Jorge Officer | Sold (automatic/other) | -68K 0.08% of company | sold 2.4% | 2.77M | $1.4M at $20.02 | Jul 10, 26 |
Santos Da Silva Jorge Officer | Sold (automatic/other) | -34K 0.04% of company | sold 1.2% | 2.84M | $679K at $20.01 | Jul 9, 26 |
Santos Da Silva Jorge Officer | Sold (automatic/other) | -48K 0.06% of company | sold 1.6% | 2.88M | $957K at $20.03 | Jul 1, 26 |
Bodenstedt Matthias Officer | Sold (automatic/other) | -39K 0.05% of company | sold 3.4% | 1.12M | $862K at $22.04 | Jun 22, 26 |
Bodenstedt Matthias Officer | Sold (automatic/other) | -3K | sold 0.2% | 1.15M | $55K at $19.60 | Jun 18, 26 |
Reich Kristian Officer | Sold (automatic/other) | -50K 0.06% of company | sold 1.7% | 2.82M | $972K at $19.43 | Jun 17, 26 |
Bodenstedt Matthias Officer | Sold (automatic/other) | -15K 0.02% of company | sold 1.3% | 1.16M | $297K at $19.68 | Jun 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on MLTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MLTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MLTX last traded at $11.41, up 0.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is next expected to report earnings on Wednesday, November 4, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MLTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MLTX 89 times in the last 30 days.
MLTX (MoonLake Immunotherapeutics Class A Ordinary Shares) trades on XNAS, with a market cap of about $969M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MLTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MLTX discussion
Sign in to ask a question or join the discussion.